← The Wire
VRDNNasdaq
Viridian Therapeutics, Inc.DE
Pharmaceutical Preparations · DE · CIK 1590750
Viridian Therapeutics develops and commercializes medicines for serious and rare diseases, focusing on autoimmune disorders and thyroid eye disease
$1.81B
Market cap
$18.79
Last close
+5.0%
1D
+6.6%
5D
7.6M
Volume
Price · last 39 sessions+33.6%
May 4L $14.06 · H $18.79Jun 29
336
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end
8-KReg FD Disclosure · Company UpdateJun 29, 20268-KShareholder VoteJun 3, 20268-KAgreement TerminatedMay 28, 20268-KMaterial AgreementMay 26, 2026SC 13D/ASC 13D/AMay 13, 20268-KMaterial Agreement · New Debt / ObligationMay 11, 2026424B5424B5May 8, 2026424B5424B5May 8, 2026424B5424B5May 6, 2026424B5424B5May 6, 20268-KReg FD DisclosureMay 5, 202610-Q10-QMay 5, 20268-KResults of OperationsMay 5, 2026DEFA14ADEFA14AApr 17, 2026DEF 14ADEF 14AApr 17, 20268-KReg FD DisclosureMar 30, 202610-K10-KFeb 26, 20268-KResults of OperationsFeb 26, 202610-Q10-QNov 5, 20258-KResults of OperationsNov 5, 20258-KMaterial AgreementOct 23, 2025424B5424B5Oct 23, 2025424B5424B5Oct 21, 20258-KResults of OperationsOct 21, 20258-KMaterial AgreementOct 20, 202510-Q10-QAug 6, 20258-KResults of OperationsAug 6, 20258-KMaterial Agreement · Reg FD DisclosureJul 30, 20258-KExecutive Change · Shareholder VoteJun 24, 20258-KReg FD DisclosureMay 20, 202510-Q10-QMay 6, 20258-KResults of OperationsMay 6, 2025DEFA14ADEFA14AApr 25, 2025DEF 14ADEF 14AApr 25, 20258-KExecutive Change · Reg FD DisclosureApr 7, 20258-KExecutive ChangeMar 10, 2025424B5424B5Mar 4, 20258-KMaterial Agreement · Agreement TerminatedMar 4, 202510-K10-KMar 3, 20258-KResults of OperationsFeb 27, 20258-KExecutive ChangeJan 10, 20258-KReg FD Disclosure · Company UpdateDec 16, 202410-Q10-QNov 12, 20248-KResults of Operations · Reg FD DisclosureNov 12, 2024424B5424B5Sep 13, 20248-KMaterial AgreementSep 12, 2024424B5424B5Sep 10, 20248-KReg FD Disclosure · Company UpdateSep 10, 20248-KResults of OperationsAug 8, 202410-Q10-QAug 8, 20248-KReg FD DisclosureJul 15, 20248-KExecutive Change · Shareholder VoteJun 20, 2024DEFA14ADEFA14AJun 10, 202410-Q10-QMay 8, 20248-KResults of OperationsMay 8, 2024DEFA14ADEFA14AApr 26, 2024DEF 14ADEF 14AApr 26, 20248-KMaterial AgreementApr 16, 202410-K10-KFeb 27, 20248-KResults of OperationsFeb 27, 2024SC 13GSC 13GJan 29, 2024SC 13GSC 13GJan 24, 20248-KMaterial Agreement · Results of OperationsJan 19, 2024424B5424B5Jan 19, 2024424B5424B5Jan 17, 2024SC 13GSC 13GJan 10, 20248-KExecutive Change · Reg FD DisclosureJan 8, 20248-KBylaw Amendment · Reg FD DisclosureDec 18, 2023SC 13GSC 13GDec 8, 202310-Q10-QNov 13, 20238-KResults of OperationsNov 13, 20238-KExecutive Change · Bylaw AmendmentNov 2, 20238-KExecutive Change · Material AgreementOct 30, 20238-KExecutive ChangeSep 25, 20238-KExecutive ChangeSep 12, 202310-Q10-QAug 8, 20238-KReg FD DisclosureJul 17, 20238-KReg FD DisclosureJul 10, 20238-KExecutive Change · Shareholder VoteJun 16, 2023SC 13GSC 13GMay 11, 2023
Insider Activity
In the 90 days to Dec 31, 2025: 1 insider bought $10.0M · 1 sold $71K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 31, 2025 | Tousignant JenniferChief Legal Officer | Sell | 2,272 | $31.16 | $71K |
| Oct 23, 2025 | Fairmount Healthcare Fund Ii Gp LlcDirector,TenPercentOwner | Buy | 454,545 | $22.00 | $10.0M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance